Prevalence of Sarcopenia in Geriatric Patients

NCT ID: NCT04124575

Last Updated: 2019-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-10

Study Completion Date

2019-10-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To assess the prevalence of sarcopenia among inpatients on acute geriatrics and geriatric rehabilitation wards of a Swiss university department of geriatric medicine using the most recent diagnosis definitions from european guidelines.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- All patients \>65 years old admitted to acute geriatrics and geriatric rehabilitation at the study site

Exclusion Criteria

* Lack of informed written consent
* Implanted defibrillation device
* Acute Sepsis, severe volume overload or dehydration
* Life expectancy of \< 3 months according to treating physician
* Unremovable bandages
* Patients in isolation rooms on the ward
* Measurement is not possible due to organizational reasons
* Inability to follow the procedures, e.g. due to language problems, psychological disorders
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Department of Geriatric Medicine FELIX PLATTER

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dominic K. Bertschi, Dr.

Role: PRINCIPAL_INVESTIGATOR

University Department of Geriatric Medicine FELIX PLATTER

Caroline Kiss, Dr.

Role: STUDY_CHAIR

University Department of Geriatric Medicine FELIX PLATTER

Reto W. Kressig, Prof. Dr.

Role: STUDY_DIRECTOR

University Department of Geriatric Medicine FELIX PLATTER

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Department of Geriatric Medicine FELIX PLATTER

Basel, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BASEC 2019-01461

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Muscle Biopsies in Healthy Volunteers
NCT01431677 TERMINATED NA
Understanding Acute Sarcopenia
NCT03858192 UNKNOWN NA
Respiratory Sarcopenia in Older Adults
NCT06548984 NOT_YET_RECRUITING NA